Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-12-07 | 2024-01-11 | 212717 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Actual shortage | 2024-01-18 | 2024-01-25 | 216463 |
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2017-04-25 | 2018-01-03 | 8055 |
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2017-08-01 | 2017-10-17 | 17832 |
| REMIFENTANIL FOR INJECTION | 1MG | POWDER FOR SOLUTION | Actual shortage | 2020-01-24 | 2020-01-24 | 104313 |
| REMIFENTANIL FOR INJECTION | 2MG | POWDER FOR SOLUTION | Actual shortage | 2020-01-24 | 2020-01-24 | 104316 |
| REVIA | 50MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190707 |
| REVIA | 50MG | TABLET | Resolved | 2024-01-11 | 2024-02-13 | 215710 |
| SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-27 | 2019-09-27 | 94940 |
| SEASONALE | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126038 |
| SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176815 |
| SEASONIQUE | 0.01MG 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2021-03-25 | 94905 |
| SEASONIQUE | 0.01MG 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126035 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2017-08-01 | 2018-05-11 | 17844 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2019-09-26 | 2019-10-04 | 94825 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-01-28 | 2021-04-08 | 132672 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-05-06 | 2021-06-10 | 138904 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-24 | 2021-07-15 | 141463 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-08-27 | 2021-09-23 | 144726 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-09-16 | 2022-04-21 | 145780 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |